Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Precigen, Inc. - Common Stock (NQ:PGEN)

1.620 +0.010 (+0.62%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Precigen, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Hibbett, American Software, Ardelyx And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Cisco, Children's Place, LSI Industries And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly higher, with the Dow Jones gaining around 75 points on Thursday. Here are some big stocks recording gains in today’s session. LSI Industries Inc. (NASDAQ: LYTS) jumped 21.8%... 
Via Benzinga
Topics Stocks
Cano Health, Maxeon Solar Technologies, Velo3D And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures traded mixed this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Precigen's Earnings: A Preview
Via Benzinga
Recap: Precigen Q1 Earnings
Via Benzinga
Precigen Regains Rights To CAR-T Platform For Hematological, Solid Tumor Indications
Via Benzinga
Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 350 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Morgan Stanley, Charles Schwab, Bank of America, And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded mostly higher, with the Dow Jones gaining over 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Precigen's Return On Capital Employed Insights
Via Benzinga
Earnings Preview For Precigen
Via Benzinga
The Immunotherapy Market Is Expected To Surpass $351.56 Billion By 2030 – Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) Is Contributing to This Growth
Immunotherapy, in general, is an exciting and growing sector in the pharmaceutical industry. It involves manipulating the human body's immune system to treat various diseases. While historically this... 
Via Benzinga
Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord. 
Via Benzinga
New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action
FN Media Group Presents USA News Group News Commentary Vancouver, BC – June 8, 2023 – USA News Group – By utilizing newly developed novel mechanisms, biotech researchers and scientists are making... 
Via FinancialNewsMedia
3 Penny Stocks That Could Skyrocket in the Next 12 Months
Find the top penny stocks to buy, and you can make a fortune. Pick the wrong one and there are also plenty of horrors. 
Via InvestorPlace
Precigen Touts Encouraging Data From Autologous UltraCAR-T Cells Manufactured Overnight For Next Day Infusion In Ovarian Cancer
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
Via Benzinga
Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich … or Broke.
Explore the world of high-risk penny stocks, with their potential for significant returns, as we analyze three speculative opportunities. 
Via InvestorPlace
7 High-Potential Penny Stocks in the Biotech Sector
Most of the biggest biotech stocks on the market started off as unknown penny stocks. Here are seven hot ones to consider. 
Via InvestorPlace
3 High-Growth Biotech Stocks Poised for Success in 2023
If you look for growth opportunities wherever you can find them, there are some high-growth biotech stocks that could present an opportunity 
Via InvestorPlace
3 Healthcare Stocks Insiders Are Buying
The healthcare industry is looking forward to double-digit growth, and these stocks the insiders are buying have analyst support too. 
Via MarketBeat
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years
Biotechs are capable of making huge gains in short periods, and they often do. 
Via The Motley Fool
Founders at These 7 Companies Are Loading Up on Their Stock. Should You?
Insiders sell for all kinds of reasons. There’s only one reason for insider buying. These seven founders and CEOs are loading up. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on! 
Via InvestorPlace
3 Penny Stocks The Insiders Are Buying
The insiders are buying these penny stocks with support from analysts and institutions. Could they be the next big winners? 
Via MarketBeat
Topics Intellectual Property
Why Altimmune, Foghorn Therapeutics, and Precigen Shares Crashed This Week
Concerns about a tough financing environment weighed on clinical-stage biotech stocks this week. 
Via The Motley Fool
Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response
New hope may be on the horizon for sufferers of Recurrent Respiratory Papillomatosis, or RRP, a rare and debilitating disease that typically requires patients to undergo multiple surgeries each year to... 
Via Benzinga
Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response
Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response 
Via News Direct
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS